What are the WHO recommendations for first-line antiviral therapy in patients with hepatitis B (HBV) (Hep B) and HIV infection?

Updated: Jun 08, 2021
  • Author: Nikolaos T Pyrsopoulos, MD, PhD, MBA, FACP, AGAF; Chief Editor: BS Anand, MD  more...
  • Print

In HBV/HIV-coinfected individuals aged 3 years or older, a fixed-dose combination of tenofovir/lamivudine (or emtricitabine)/efavirenz is the preferred option for initiation of ART.

Did this answer your question?
Additional feedback? (Optional)
Thank you for your feedback!